# STAAR-2 Clinical Study

> **NCT00368901** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 618 (actual)

## Conditions studied

- Chronic Kidney Disease
- Chronic Renal Insufficiency
- Kidney Disease
- Pre-dialysis
- Pre-ESRD

## Interventions

- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00368901
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2004-03
- **Final completion:** 2004-05
- **Target enrollment:** 618 (ACTUAL)
- **Last updated:** 2010-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368901, "STAAR-2 Clinical Study". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00368901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*